Abionyx Pharma SA
LSE:0RAG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abionyx Pharma SA
LSE:0RAG
|
FR |
|
S
|
Schlumberger NV
SWB:SCL
|
US |
|
Digipath Inc
OTC:DIGP
|
US |
|
Insurance Australia Group Ltd
ASX:IAG
|
AU |
|
A
|
AO World PLC
SWB:81A
|
UK |
|
Vimian Group AB
F:0V0
|
SE |
|
Pattern SpA
MIL:PTR
|
IT |
|
Krungthai Card PCL
OTC:KGTHY
|
TH |
|
H
|
Heidelberger Druckmaschinen AG
LSE:0OC2
|
DE |
|
E
|
Eutelsat Communications SA
XBER:E3B
|
FR |
|
S
|
Seek Ltd
SWB:SLD
|
AU |
|
A
|
Adidas AG
LSE:0OLD
|
DE |
|
V
|
Visa Inc
XBER:3V64
|
US |
|
C
|
CME Group Inc
DUS:MX4A
|
US |
|
Elior Group SA
F:21E
|
FR |
|
Barsele Minerals Corp
XTSX:FNM
|
CA |
|
A
|
Associated British Foods PLC
OTC:ASBFF
|
UK |
|
P
|
PowerBand Solutions Inc
OTC:PWWBF
|
CA |
|
O
|
O'Reilly Automotive Inc
DUS:OM6
|
US |
|
C
|
CrowdStrike Holdings Inc
F:45C
|
US |
|
Oil and Natural Gas Corporation Ltd
BSE:500312
|
IN |
|
W
|
Waters Corp
F:WAZ
|
US |
|
L
|
Lucara Diamond Corp
F:LKT
|
CA |
|
T
|
Townsquare Media Inc
XBER:2T8
|
US |
Bankruptcy Probability
Abionyx Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Abionyx Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Abionyx Pharma SA
PAR:ABNX
|
109.1m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Abionyx Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Abionyx Pharma SA has total debt of 3m EUR. This includes both short-term (0 EUR) and long-term (3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
